The Eli and Edythe Broad Foundation in Los Angeles has awarded gifts totaling $30 million in support of research, training, and faculty recruitment and retention efforts at namesake Eli and Edyth Broad stem cell research centers in California.
The gifts of $10 million each will support ongoing stem cell research at centers located at the University of Southern California, the University of California, Los Angeles, and the University of California, San Francisco. USC will use its funding to further apply stem cell technologies to diseases associated with aging; UCLA will work to advance promising therapies in stem cell gene modification, stem cell immunotherapy, cell replacement strategies, and drug discovery, from the discovery phase to clinical trials; and UCSF will launch a pilot initiative that seeks to better diagnose and treat developmental disorders.
A portion of the funding will be distributed through the Broad Innovation Awards program, an initiative designed to encourage collaboration among stem cell researchers, engineers, biologists, and experts in related fields.
"We are proud to support the scientists and staff at the Broad stem cell centers at USC, UCLA, and UCSF who are leading our state's growing stem cell research and treatment infrastructure," said Broad Foundation president Gerun Riley. "With the centers' commitment to training scientists, and their advances in identifying potential treatments for cancers, heritable disorders, and more, we are hopeful that the centers will make life-changing medical breakthroughs possible for people around the world."